Synthomer extends covenant waivers, shares slide.


Shares in chemicals business Synthomer were down double-digits early on Tuesday after an extension to its covenant relaxation period sparked fresh concerns over its debt levels and earnings outlook.

  • Synthomer
  • 05 August 2025 08:49:06
Synthomer

Source: Sharecast

Synthomer said it had reached an agreement with its banking syndicate to extend covenant waivers through to the end of 2026. Under the revised terms, net debt-to-EBITDA thresholds will be raised significantly, allowing it more breathing room amid what it described as "weaker-than-expected trading conditions and ongoing geopolitical uncertainty".

Synthomer also said revenues had fallen 9.8% to £925.2m in the six months ended 30 June, with volumes down 7.1%, driven by volatile end-market demand following recent tariff changes.

However, underlying earnings rose 5.4% to £77.8m, with margins improving by 110 basis points to 8.4%, supported by £17m in cost savings and pricing discipline.

Synthomer said its adhesive solutions division delivered the strongest performance, with EBITDA up 65% and margins nearing 12%, while its health and protection division also saw gains, aided by higher-margin glove products and new income streams from a US technology partnership. Its coatings and construction arm saw mixed conditions, with energy solutions impacted by reduced oil and gas drilling activity.

The London-listed firm, which also said net debt rose from £560.6m to £638.3m, added that it continues to expect a H2 improvement in performance, supported by restructuring benefits and stabilising demand in key markets.

CEO Michael Willome said: "While our 'in region for region' manufacturing strategy means we face limited direct tariff impact, the ongoing uncertainties around the global trade environment create volatility in end-market demand. We continue to focus on managing our costs and our balance sheet to ensure we emerge from this turbulent period for our industry in a strong position."

As of 0840 BST, Synthomer shares had sunk 11.17% to 70p.

Reporting by Iain Gilbert at Sharecast.com


N/A

ISIN: N/A
Exchange: N/A
Sell:
N/A
Buy:
N/A
Change:
Date:
Prices delayed by at least 15 minutes

Compare our accounts

If you're looking to grow your money over the longer term (5+ years), we have a range of investment choices to help.

Halifax is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.